Related Experiment Video

Updated: Apr 26, 2026

A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent Serum
07:06

A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent Serum

Published on: April 10, 2018

8.3K

Dengue virus and host antibody: a dangerous balancing act

Brett A Lidbury1, Suresh Mahalingam2

  • 1John Curtin School of Medical Research, Australian National University, Australian Capital Territory, Australia.

The Lancet. Infectious Diseases
|August 5, 2014
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Quantification of Antibody-dependent Enhancement of the Zika Virus in Primary Human Cells
07:53

Quantification of Antibody-dependent Enhancement of the Zika Virus in Primary Human Cells

Published on: January 18, 2019

8.2K
Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction
08:36

Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction

Published on: November 1, 2018

33.7K

Related Experiment Videos

Last Updated: Apr 26, 2026

A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent Serum
07:06

A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent Serum

Published on: April 10, 2018

8.3K
Quantification of Antibody-dependent Enhancement of the Zika Virus in Primary Human Cells
07:53

Quantification of Antibody-dependent Enhancement of the Zika Virus in Primary Human Cells

Published on: January 18, 2019

8.2K
Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction
08:36

Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction

Published on: November 1, 2018

33.7K

Related Concept Videos

Arboviral Encephalitis01:25

Arboviral Encephalitis

52
Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
52
Cross-reactivity00:42

Cross-reactivity

28.7K
Overview
28.7K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

2.3K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.3K

Articles linked to this work by shared authors, journal, and citation graph.

Addressing the zoonotic threat of merbecoviruses.

Nature microbiology·2026

Distinct inflammatory biomarkers associated with rheumatological outcomes in chronic chikungunya disease.

Scientific reports·2026

Combating respiratory diseases with mucosal vaccines.

Journal of virology·2026

The ability of alphavirus replicases to synthesize non-viral type I interferon-inducing RNAs correlates with viral RNA synthesis and has a diverse impact on virus replication and pathogenicity.

Journal of virology·2026

Adjuvant-free biopolymer particles mimicking the Chikungunya virus surface induce protective immunity.

Biomaterials·2026

Epstein-Barr Virus, Lower Vitamin D, Low Sun Exposure, and HLA-DRB1*1501 Risk Variant Share Common Epigenetic Pathways Leading to Multiple Sclerosis Onset.

Annals of neurology·2025

Guiding principles for pragmatic randomised trials of tuberculosis treatments.

The Lancet. Infectious diseases·2026

Clinical, molecular, and in vitro evidence of artemisinin partial resistance in Ethiopian Plasmodium falciparum: a prospective, multisite, surveillance study.

The Lancet. Infectious diseases·2026

Efficacy, immunogenicity, and safety of the 9-valent human papillomavirus vaccine in males aged 16-26 years in Japan: a randomised, double-blind, placebo-controlled trial.

The Lancet. Infectious diseases·2026

A review of Bundibugyo virus and the 2026 outbreak: lessons for epidemic preparedness.

The Lancet. Infectious diseases·2026

Impact of directly observed treatment and extended age range of seasonal malaria chemoprevention with sulfadoxine-pyrimethamine plus amodiaquine in Burkina Faso: a three-group, open-label, cluster-randomised, controlled trial.

The Lancet. Infectious diseases·2026

Baloxavir marboxil, favipiravir, or oseltamivir in patients with non-severe symptomatic seasonal influenza (AD ASTRA): a phase 2, open-label, adaptive, randomised controlled trial.

The Lancet. Infectious diseases·2026

Impact of immune function and white matter integrity on cognitive function in patients with bipolar disorder.

Frontiers in immunology·2026

Brunner's Gland hyperplasia presenting with melenic stools and microcytic anemia: A case report.

Journal of family medicine and primary care·2026

In-depth evaluation of false-positive biological reactions in the syphilis serological diagnosis: a cross-sectional study with two sampling components.

Frontiers in cellular and infection microbiology·2026

The Therapeutic Paradox of Endocannabinoid Immunomodulation: Molecular Mechanisms and Strategic Frameworks.

International journal of molecular sciences·2026

Predictive value of the admission IBIL/TBIL ratio for poor prognosis after surgical treatment of intracerebral hemorrhage.

Frontiers in neurology·2026

Assessment of Hemolysis, Icterus, and Lipemia Interference in 14 Clinical Chemistry and 5 Immunoassay Parameters.

Clinical laboratory·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us